364 related articles for article (PubMed ID: 15184894)
1. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
3. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy.
Grewal PK; Hewitt JE
Biochim Biophys Acta; 2002 Dec; 1573(3):216-24. PubMed ID: 12417403
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation eases muscular dystrophy.
Muntoni F; Brockington M; Brown SC
Nat Med; 2004 Jul; 10(7):676-7. PubMed ID: 15229511
[No Abstract] [Full Text] [Related]
5. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
6. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
7. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
Toda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation defects in muscular dystrophies.
Haliloğlu G; Topaloğlu H
Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
[TBL] [Abstract][Full Text] [Related]
10. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
11. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
Martin-Rendon E; Blake DJ
Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
[TBL] [Abstract][Full Text] [Related]
12. Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.
Henion TR; Qu Q; Smith FI
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):177-81. PubMed ID: 12670716
[TBL] [Abstract][Full Text] [Related]
13. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
14. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
15. The role of defective glycosylation in congenital muscular dystrophy.
Schachter H; Vajsar J; Zhang W
Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
[TBL] [Abstract][Full Text] [Related]
16. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
[TBL] [Abstract][Full Text] [Related]
17. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
18. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse.
Grewal PK; Holzfeind PJ; Bittner RE; Hewitt JE
Nat Genet; 2001 Jun; 28(2):151-4. PubMed ID: 11381262
[TBL] [Abstract][Full Text] [Related]
19. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
20. Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression.
Ohtsuka Y; Kanagawa M; Yu CC; Ito C; Chiyo T; Kobayashi K; Okada T; Takeda S; Toda T
Sci Rep; 2015 Feb; 5():8316. PubMed ID: 25661440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
